Research Applications of L-Thyroxine Sodium
Levotiron 75 represents a pharmaceutical-grade preparation of L-thyroxine sodium (LT4), a synthetic thyroid hormone extensively studied in metabolic research. This compound is structurally identical to the endogenous thyroid hormone thyroxine and serves as a critical research tool for investigating thyroid hormone signalling pathways, metabolic regulation, and cellular energy expenditure mechanisms. Researchers at Stroid UK Shop utilise this compound to examine thyroid hormone receptor interactions, nuclear transcription factor modulation, and mitochondrial biogenesis pathways in controlled laboratory environments.
In metabolic research contexts, L-thyroxine sodium enables scientists to investigate its role in regulating basal metabolic rate, thermogenesis, and lipid metabolism. The compound demonstrates significant effects on protein synthesis, carbohydrate metabolism, and cellular respiration in experimental models. Research applications extend to studying thyroid hormone resistance syndromes, metabolic dysfunction disorders, and the intricate relationship between thyroid function and metabolic modulator compounds. Laboratory studies frequently examine LT4’s interaction with other endocrine pathways, particularly its effects on growth hormone secretion and insulin sensitivity.
Molecular Characterisation and Research Properties
L-thyroxine sodium exhibits a well-characterised molecular structure with the formula C15H10I4NNaO4, providing researchers with a standardised reference compound for thyroid hormone studies. The sodium salt formulation ensures optimal solubility and stability for in-vitro applications. Research demonstrates that LT4 functions primarily through binding to thyroid hormone receptors (TRα and TRβ), initiating genomic and non-genomic cellular responses. This mechanism makes it particularly valuable for studying nuclear receptor biology and transcriptional regulation processes. Scientists investigating selective androgen receptor modulators often use thyroid hormones as comparative compounds to understand nuclear receptor specificity and tissue-selective effects.
The compound’s pharmacokinetic properties in research models reveal extensive protein binding and hepatic deiodination pathways, providing insights into hormone metabolism and clearance mechanisms. Laboratory studies examining peptide hormones frequently incorporate thyroid hormone research to understand complex endocrine interactions and metabolic cascades.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | L-Thyroxine Sodium (LT4) |
| Manufacturer | Abdi Ibrahim |
| Strength | 75 mcg per tablet |
| CAS Number | 25416-65-3 |
| Molecular Formula | C15H10I4NNaO4 |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | Thyroid hormone studies, metabolic research |
| Stability | Stable under recommended storage conditions |
Compliance and Research Use Declaration
This product is supplied strictly for in-vitro laboratory research purposes only. Levotiron 75 Abdi Ibrahim is intended for qualified researchers investigating thyroid hormone biology, metabolic pathways, and endocrine system interactions in controlled laboratory settings. This compound is not intended for human consumption, therapeutic use, or any application outside accredited research facilities. Researchers must ensure compliance with local regulations governing the handling and investigation of thyroid hormone compounds and maintain appropriate laboratory safety protocols during experimental procedures.
